RecallHawk

INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION)

NOVO NORDISK INC

Summary

FDA approved INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION) by NOVO NORDISK INC. BLA (Biologic) approval (Labeling) on 2023-02-28. INJECTABLE, SUBCUTANEOUS.

Details

Source

Drug Approval

External ID

BLA020986-96

Action Date

2023-02-28

Status

Approved

Category

drug

Product Code

BLA (Biologic)

Product Description

INSULIN DILUTING MEDIUM FOR NOVOLOG (generic: WATER INJECTION), INJECTABLE, SUBCUTANEOUS. Application: BLA020986

Context & Analysis

NOVO NORDISK INC has 6 FDA actions in our database, including 2 recalls and 1 clearance.

Frequently Asked Questions

How often does NOVO NORDISK INC have FDA actions?

NOVO NORDISK INC has 6 FDA actions in our database, including 2 recalls and 1 device clearance.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "BLA020986-96" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions